Women make up the majority of GLP-1 drug users \u2014 approximately 65-70% of prescriptions for semaglutide and tirzepatide are written for women. Women also tend to experience greater weight loss on GLP-1 drugs than men, a finding that has been consistent across multiple clinical trials. In the SURMOUNT-1 trial for tirzepatide, women lost an average of 22% while men lost 18%. The TRIUMPH-4 and TRIUMPH-1 data for retatrutide has not been broken down by sex, but the same pattern is expected: women may lose slightly more weight than the reported averages due to biological differences in fat distribution and hormone metabolism.<\/p>\n
Beyond weight loss, retatrutide’s potential benefits for women include improved insulin sensitivity, which is particularly relevant for the estimated 5-10% of women with PCOS, and reduced inflammation, which may help with conditions like endometriosis and autoimmune disease. The weight loss itself has downstream effects on fertility, menstrual regularity, and pregnancy outcomes \u2014 losing 5-10% of body weight can restore ovulation in some women with PCOS-related infertility. These benefits are not specific to retatrutide and apply to any effective weight loss intervention, but retatrutide’s superior efficacy may produce them more reliably.<\/p>\n
The TRIUMPH dosing protocol \u2014 2 mg starting dose titrated up to 12 mg over 12 weeks \u2014 applies equally to men and women. Some female users on Reddit report that they find lower doses effective and stay at 4-8 mg rather than titrating to 12 mg. The Phase 2 data supports this: 4 mg produced 15-17% weight loss and 8 mg produced 20-22%, both of which are clinically meaningful. Women who are closer to their goal weight or who have lower starting BMIs may not need the maximum dose to achieve their desired results.<\/p>\n","protected":false},"excerpt":{"rendered":"
Why Women May Respond Differently to Retatrutide Women make up the majority of GLP-1 drug users \u2014 approximately 65-70% of prescriptions for semaglutide and tirzepatide are written for women. Women also tend to experience greater weight loss on GLP-1 drugs than men, a finding that has been consistent across multiple clinical trials. In the SURMOUNT-1 […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-53","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=\/wp\/v2\/posts\/53","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=53"}],"version-history":[{"count":0,"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=\/wp\/v2\/posts\/53\/revisions"}],"wp:attachment":[{"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=53"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=53"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=53"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}